TY - JOUR
T1 - Unit policies regarding tocolysis after preterm premature rupture of membranes
T2 - association with latency, neonatal and 2-year outcomes (EPICE cohort)
AU - Lorthe, Elsa
AU - Moreira, Carla
AU - Weber, T.
AU - Huusom, Lene D.
AU - Schmidt, Stephan
AU - Maier, R. F.
AU - Jarreau, P. H.
AU - Cuttini, M.
AU - Draper, Elizabeth S.
AU - Zeitlin, Jennifer
AU - Barros, H.
AU - Martens, E.
AU - Martens, G.
AU - Van Reempts, P.
AU - Boerch, K.
AU - Hasselager, A.
AU - Huusom, L.
AU - Pryds, O.
AU - Weber, T.
AU - Toome, L.
AU - Varendi, H.
AU - Ancel, P. Y.
AU - Blondel, B.
AU - Burguet, A.
AU - Jarreau, P. H.
AU - Truffert, P.
AU - Maier, R. F.
AU - Misselwitz, B.
AU - Schmidt, S.
AU - Gortner, L.
AU - Baronciani, D.
AU - Gargano, G.
AU - Agostino, R.
AU - Croci, I.
AU - Franco, F.
AU - Carnielli, V.
AU - Cuttini, M.
AU - DiLallo, D.
AU - Koopman-Esseboom, C.
AU - Van Heijst, A.
AU - Nijman, J.
AU - Gadzinowski, J.
AU - Mazela, J.
AU - Graça, L. M.
AU - Machado, M. C.
AU - Rodrigues, C.
AU - Rodrigues, T.
AU - Barros, H.
AU - Bonamy, A. K.
AU - Norman, M.
PY - 2020/12/1
Y1 - 2020/12/1
N2 - After preterm premature rupture of membranes (PPROM), antibiotics and antenatal steroids are effective evidence-based interventions, but the use of tocolysis is controversial. We investigated whether a unit policy of tocolysis use after PPROM is associated with prolonged gestation and improved outcomes for very preterm infants in units that systematically use these other evidence-based treatments. From the prospective, observational, population-based EPICE cohort study (all very preterm births in 19 regions from 11 European countries, 2011–2012), we included 607 women with a singleton pregnancy and PPROM at 24–29 weeks’ gestation, of whom 101, 195 and 311 were respectively managed in 17, 32 and 45 units with no-use, restricted and liberal tocolysis policies for PPROM. The association between unit policies and outcomes (early-onset sepsis, survival at discharge, survival at discharge without severe morbidity and survival at two years without gross motor impairment) was investigated using three-level random-intercept logistic regression models, showing no differences in neonatal or two-year outcomes by unit policy. Moreover, there was no association between unit policies and prolongation of gestation in a multilevel survival analysis. Compared to a unit policy of no-use of tocolysis after PPROM, a liberal or restricted policy is not associated with improved obstetric, neonatal or two-year outcomes.
AB - After preterm premature rupture of membranes (PPROM), antibiotics and antenatal steroids are effective evidence-based interventions, but the use of tocolysis is controversial. We investigated whether a unit policy of tocolysis use after PPROM is associated with prolonged gestation and improved outcomes for very preterm infants in units that systematically use these other evidence-based treatments. From the prospective, observational, population-based EPICE cohort study (all very preterm births in 19 regions from 11 European countries, 2011–2012), we included 607 women with a singleton pregnancy and PPROM at 24–29 weeks’ gestation, of whom 101, 195 and 311 were respectively managed in 17, 32 and 45 units with no-use, restricted and liberal tocolysis policies for PPROM. The association between unit policies and outcomes (early-onset sepsis, survival at discharge, survival at discharge without severe morbidity and survival at two years without gross motor impairment) was investigated using three-level random-intercept logistic regression models, showing no differences in neonatal or two-year outcomes by unit policy. Moreover, there was no association between unit policies and prolongation of gestation in a multilevel survival analysis. Compared to a unit policy of no-use of tocolysis after PPROM, a liberal or restricted policy is not associated with improved obstetric, neonatal or two-year outcomes.
UR - http://www.scopus.com/inward/record.url?scp=85086377290&partnerID=8YFLogxK
U2 - 10.1038/s41598-020-65201-y
DO - 10.1038/s41598-020-65201-y
M3 - Article
C2 - 32533019
AN - SCOPUS:85086377290
SN - 2045-2322
VL - 10
JO - Scientific Reports
JF - Scientific Reports
IS - 1
M1 - 9535
ER -